Analytical Data
-
Gene name
SLC25A45
- Application
-
Alternative Names
SLC25A45; Solute carrier family 25 member 45
-
Species
Human
-
Source
Baculovirus
-
Tag
N-MBP;C-Flag;N-8*His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N413
-
Expression Region
P2-G288
-
Protein Length
Partial
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC25A45, a member of the solute carrier family of proteins, is primarily known for its role as a mitochondrial transporter. Recent research has highlighted its involvement in various cellular processes, including mitochondrial metabolism, calcium homeostasis, and apoptosis regulation. Dysregulation of SLC25A45 has been implicated in several diseases, such as metabolic disorders and neurodegenerative conditions, making it a potential target for therapeutic interventions. Moreover, the study of SLC25A45 recombinant proteins has become essential for understanding its structure-function relationship, elucidating its transport mechanisms, and exploring its role in cellular homeostasis. By producing recombinant SLC25A45, researchers can investigate its biochemical properties and interactions with other mitochondrial components. This research not only offers insights into the fundamental biology of mitochondrial transporters but also provides a foundation for developing novel treatments for diseases linked to mitochondrial dysfunction. As we delve deeper into the functional characteristics of SLC25A45 through recombinant protein studies, we aim to uncover its potential as a biomarker or therapeutic target in mitochondrial-related pathologies, thus contributing to the broader understanding of mitochondrial biology and its implications in human health.
